BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 34753486)

  • 21. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
    Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis.
    Zhou ZF; Wei Z; Yao JC; Liu SY; Wang F; Wang Z; Chen XF; Lin H; Ye Y; Zheng QF
    Pathol Res Pract; 2020 Nov; 216(11):153144. PubMed ID: 32911346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
    Duan Z; Wei S; Liu Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer.
    Yang B; Teng F; Chang L; Wang J; Liu DL; Cui YS; Li GH
    Aging (Albany NY); 2021 May; 13(9):13264-13286. PubMed ID: 33952725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
    Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
    J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
    Zheng S; Wang C; Yan H; Du Y
    Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z; Yin J; Peng G; Long X
    Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-transported circ_0061407 and circ_0008103 play a tumour-repressive role and show diagnostic value in non-small-cell lung cancer.
    Chen Z; Ma X; Chen Z; Chen W; Li L; Lin Y; Hu Y; Shang Y; Zhao Y; He J; Zhou C; Meng X
    J Transl Med; 2024 May; 22(1):427. PubMed ID: 38711144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
    Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
    Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
    J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA HIPK3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging miR-149.
    Lu H; Han X; Ren J; Ren K; Li Z; Sun Z
    Cancer Biol Ther; 2020; 21(2):113-121. PubMed ID: 31597523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2.
    Kim DH; Park H; Choi YJ; Kang MH; Kim TK; Pack CG; Choi CM; Lee JC; Rho JK
    Cell Death Dis; 2021 Jul; 12(8):747. PubMed ID: 34321461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1.
    Gao J; Ao YQ; Zhang LX; Deng J; Wang S; Wang HK; Jiang JH; Ding JY
    J Exp Clin Cancer Res; 2022 Oct; 41(1):295. PubMed ID: 36209117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.